BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38846756)

  • 1. Diagnosing vasculitis with ultrasound: findings and pitfalls.
    Schmidt WA; Schäfer VS
    Ther Adv Musculoskelet Dis; 2024; 16():1759720X241251742. PubMed ID: 38846756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular ultrasound in rheumatology practice.
    Schmidt WA
    Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101847. PubMed ID: 37419758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intima-media thickness cut-off values depicting "halo sign" and potential confounder analysis for the best diagnosis of large vessel giant cell arteritis by ultrasonography.
    Milchert M; Fliciński J; Brzosko M
    Front Med (Lausanne); 2022; 9():1055524. PubMed ID: 36582293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases.
    Boiardi L; Galli E; Macchioni P; Muratore F; Klinowski G; Hunder GG; Casali M; Besutti G; Spaggiari L; Versari A; Croci S; Mancuso P; Rossi PG; Marvisi C; Salvarani C
    Semin Arthritis Rheum; 2023 Apr; 59():152173. PubMed ID: 36780709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halo sign on temporal artery ultrasound versus temporal artery biopsy for giant cell arteritis.
    Pouncey AL; Yeldham G; Magan T; Lucenteforte E; Jaffer U; Virgili G
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD013199. PubMed ID: 38323659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inflammatory Muscle Pain: Polymyalgia Rheumatica with or without Large Vessel Vasculitis].
    Schmidt WA
    Dtsch Med Wochenschr; 2020 Jul; 145(13):895-902. PubMed ID: 32615604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu's and giant cell arteritis using positron emission tomography.
    Soriano A; Pazzola G; Boiardi L; Casali M; Muratore F; Pipitone N; Catanoso M; Aldigeri R; Cimino L; Versari A; Salvarani C
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):99-106. PubMed ID: 29799393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study.
    Kushimoto K; Ayano M; Nishimura K; Nakano M; Kimoto Y; Mitoma H; Ono N; Arinobu Y; Akashi K; Horiuchi T; Niiro H
    Arthritis Res Ther; 2021 Sep; 23(1):238. PubMed ID: 34517892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Takayasu arteritis and giant cell arteritis: a spectrum within the same disease?
    Maksimowicz-McKinnon K; Clark TM; Hoffman GS
    Medicine (Baltimore); 2009 Jul; 88(4):221-226. PubMed ID: 19593227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ultrasound in the understanding and management of vasculitis.
    Schmidt WA
    Ther Adv Musculoskelet Dis; 2014 Apr; 6(2):39-47. PubMed ID: 24688604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
    JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Large Vessel Vasculitides: Giant Cell Arteritis and Takayasu Arteritis - Similarities and Differences].
    Gloor AD; Christ L
    Ther Umsch; 2022 Jun; 79(5):221-228. PubMed ID: 35583023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of subclinical giant cell arteritis in patients with morning stiffness of duration less than 45 minutes at the time of diagnosis of polymyalgia rheumatica.
    Manzo C; Castagna A; Veronese N; Isetta M
    Reumatologia; 2023; 61(6):432-438. PubMed ID: 38322103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Giant-cell arteritis and Takayasu arteritis: epidemiological, diagnostic and treatment aspects].
    Chaigne-Delalande S; de Menthon M; Lazaro E; Mahr A
    Presse Med; 2012 Oct; 41(10):955-65. PubMed ID: 22940467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of
    Slart RHJA; Nienhuis PH; Glaudemans AWJM; Brouwer E; Gheysens O; van der Geest KSM
    J Nucl Med; 2023 Apr; 64(4):515-521. PubMed ID: 37011940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis.
    Schmidt WA; Blockmans D
    Curr Opin Rheumatol; 2005 Jan; 17(1):9-15. PubMed ID: 15604899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care.
    Molina-Collada J; Castrejón I; Monjo I; Fernández-Fernández E; Torres Ortiz G; Álvaro-Gracia JM; de Miguel E
    RMD Open; 2023 Apr; 9(2):. PubMed ID: 37094980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity?
    Furuta S; Cousins C; Chaudhry A; Jayne D
    J Rheumatol; 2015 Feb; 42(2):300-8. PubMed ID: 25399386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice.
    Dejaco C; Ramiro S; Duftner C; Besson FL; Bley TA; Blockmans D; Brouwer E; Cimmino MA; Clark E; Dasgupta B; Diamantopoulos AP; Direskeneli H; Iagnocco A; Klink T; Neill L; Ponte C; Salvarani C; Slart RHJA; Whitlock M; Schmidt WA
    Ann Rheum Dis; 2018 May; 77(5):636-643. PubMed ID: 29358285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging for Diagnosis, Monitoring, and Outcome Prediction of Large Vessel Vasculitides.
    Schäfer VS; Jin L; Schmidt WA
    Curr Rheumatol Rep; 2020 Sep; 22(11):76. PubMed ID: 32959107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.